Hypoxia-driven immunosuppression: A new reason to use thermal therapy in the treatment of cancer?

Hypoxia-Induced Decrease in p53 Protein Level and Increase in c-jun DNA Binding Activity Results in Cancer Cell Resistance to Etoposide

(2015) Jean-Philippe Cosse et al.   NEOPLASIA

Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression

(2012) Jean-Philippe Cosse et al.   Anti-Cancer Agents in Medicinal Chemistry

Acute and chronic in vivo therapeutic resistance

(2009) Beverly A. Teicher   BIOCHEMICAL PHARMACOLOGY

Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

(2009) H Harada et al.   BRITISH JOURNAL OF CANCER

Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies

(2009) Annamaria Rapisarda et al.   DRUG RESISTANCE UPDATES

Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin

(2009) Meixiang Yang et al.   IMMUNOLOGY

Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3

(2009) Karuppaiyah Selvendiran et al.   INTERNATIONAL JOURNAL OF CANCER

Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1α

(2009) Lei Huang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells

(2009) Jun Wan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Hypoxia Prolongs Monocyte/Macrophage Survival and Enhanced Glycolysis Is Associated with Their Maturation under Aerobic Conditions

(2009) J. Roiniotis et al.   JOURNAL OF IMMUNOLOGY

Imaging of HIF-1-Active Tumor Hypoxia Using a Protein Effectively Delivered to and Specifically Stabilized in HIF-1-Active Tumor Cells

(2009) T. Kudo et al.   JOURNAL OF NUCLEAR MEDICINE

Hypoxia Inducible Factor-1alpha and Vascular Endothelial Growth Factor in Biopsies of Small Cell Lung Carcinoma

(2009) M. Ioannou et al.   LUNG

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α

(2009) A Soeda et al.   ONCOGENE

T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response

(2009) Michail V. Sitkovsky   TRENDS IN IMMUNOLOGY

Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide

(2008) D. R. Siemens et al.   CANCER RESEARCH

Regulatory T Cells and Immune Tolerance

(2008) Shimon Sakaguchi et al.   CELL

Imaging of Tumor Hypoxia to Predict Treatment Sensitivity

(2008) H. Minn et al.   CURRENT PHARMACEUTICAL DESIGN

Targeting tumour hypoxia in breast cancer

(2008) Manuela Milani et al.   EUROPEAN JOURNAL OF CANCER

Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α

(2008) Jeremy Ben-Shoshan et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses

(2008) Baris E. Dayanc et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Engineering Human Tumor-specific Cytotoxic T Cells to Function in a Hypoxic Environment

(2008) Hongsung Kim et al.   MOLECULAR THERAPY

NKG2D ligands in tumor immunity

(2008) N Nausch et al.   ONCOGENE

Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis

(2008) P. Vaupel   ONCOLOGIST

NKG2D ligands: key targets of the immune response

(2008) Segundo González et al.   TRENDS IN IMMUNOLOGY